The outlook of companies tied to Viagra's past presents a complex investment scenario . While the initial boom generated substantial returns , generic alternatives have significantly impacted market share . Investing in related pharmaceutical firms now requires a careful assessment of intellectual property safeguards, evolving healthcare shifts , a